Nature

Yield of additional genetic testing after chromosomal microarray for diagnosis of neurodevelopmental disability and congenital anomalies: a clinical practice resource of the ...

Chromosomal microarray (CMA) is recommended as the first-tier test in evaluation of individuals with neurodevelopmental disability and congenital anomalies. CMA may not detect balanced cytogenomic ...
Nature

Chromosomal microarray testing in adults with intellectual disability presenting with comorbid psychiatric disorders

Chromosomal copy-number variations (CNVs) are a class of genetic variants highly implicated in the aetiology of neurodevelopmental disorders, including intellectual disabilities (ID), schizophrenia ...
Yahoo Finance

Chromosomal Microarray Market Trends, Analysis, and Forecast 2025-2034 | Rising Demand for Genetic Diagnostics, Integration with Genomic Medicine Drives Innovations and ...

Dublin, June 30, 2025 (GLOBE NEWSWIRE) -- The "Chromosomal Microarray Market Size, Share, Trends, Analysis, and Forecast 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and ...
Healio

Chromosomal microarray had highest detection rate for autism spectrum disorder abnormalities

Please provide your email address to receive an email when new articles are posted on . Chromosomal microarray analysis should be considered as a first-tier genetic diagnostic test for autism spectrum ...
technologynetworks

Thermo Fisher Scientific Updates Chromosomal Microarray Analysis Solutions To Comply With IVDR Regulation

Thermo Fisher Scientific Inc., announced that the Applied Biosystems™ CytoScan™ Dx Assay and Applied Biosystems™ Chromosomal Analysis Suite (ChAS) Dx software now comply with In Vitro Diagnostic ...